![Karen Hunady](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Hunady
Investor Relations Contact chez
SYROS PHARMACEUTICALS, INC.
Profil
Karen Hunady is currently the Director of Communications & Investor Relations at Syros Pharmaceuticals, Inc. She previously worked as the Director of Communications & Investor Relations at Athersys, Inc. Ms. Hunady has an undergraduate degree from Bowling Green State University and a graduate degree from The University of North Carolina at Wilmington.
Postes actifs de Karen Hunady
| Sociétés | Poste | Début |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Investor Relations Contact | 01/10/2022 |
Anciens postes connus de Karen Hunady
| Sociétés | Poste | Fin |
|---|---|---|
| ATHERSYS, INC. | Investor Relations Contact | - |
Formation de Karen Hunady
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Bowling Green State University
 Bowling Green State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Wilmington
 The University of North Carolina at Wilmington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Athersys, Inc.
 Athersys, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops novel and proprietary therapies | Health Technology |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
